Table 3.

Comparisons between survival and deceased patients in NEC patients

Variables	Survival, n = 87	Deceased, n = 19	P-value
Age at diagnosis, weeks	45.79 ± 24.36	57.10 ± 22.25	0.066
Gender, female (%)	38 (43.68)	7 (36.84)	0.324
Gestational age, weeks	30.97 ± 4.97	31.36 ± 4.57	0.753
Birth weight, kg	2.77 ± 0.76	2.64 ± 0.73	0.497
1-min Apgar score	6.98 ± 1.38	6.89 ± 1.41	0.790
5-min Apgar score	8.11 ± 1.36	7.78 ± 1.39	0.351
Delivery mode, n (%)			0.177
Vaginal delivery	54 (62.06)	10 (52.63)
Caesarean delivery	33 (37.93)	9 (47.37)
Surgery methods, n (%)			0.128
Laparotomy	41 (47.13)	11 (57.89)
Peritoneal Drainage	46 (52.87)	8 (42.11)
HMGB1, pg/ml	133.06 ± 59.41	445.29 ± 168.37	< 0.001
I-FABP, ng/ml	17.99 ± 4.42	34.65 ± 9.06	< 0.001
CRP, pg/ml	492.02 ± 179.51	482.41 ± 164.81	0.831
IL-1β, pg/ml	70.22 ± 21.14	118.86 ± 45.22	< 0.001
IL-6, pg/ml	78.63 ± 33.00	131.21 ± 55.80	< 0.001
TNF-α, pg/ml	458.62 ± 177.42	505.81 ± 180.03	0.297